PursueCare, a company that provides personalized virtual addiction treatment, announced the re-release of FDA-cleared RESET and RESET-O, prescription digital therapeutics (PDTs) for substance use disorder and opioid use disorder, respectively.
RESET and RESET-O were initially developed and commercialized by Pear Therapeutics, which filed for Chapter 11 bankruptcy last year. PursueCare acquired...
Pharmacy service provider Advanced Rx announced an alliance with pain-management digital health company Sure Med Compliance to give Advanced Rx sole entry to Sure Med Compliance's Perspectives in Care (PiC) to ensure proper risk and benefit analysis has been determined and recorded when a controlled substance is dispensed.
PiC delivers medicolegal understanding at the point of care and educates...
Pomelo Care, a virtual maternity care platform, announced it secured $46 million in Series B funding.
Existing investors Andreessen Horowitz (a16z) and First Round Capital led the round.
Stripes, Operator Partners, SV Angel and BoxGroup also participated in the round alongside angel investors Adam Boehler and Puneet Singh.
The New York-based company partners with employers, health plans and...
Digital substance use management platform Pelago announced it launched an inpatient Centers of Excellence network focused on increasing access to care, treatment completion, and cost reduction.
Pelago will use its substance use disorder-focused digital front door to identify members in need of a higher level of care.
The company also employs a proprietary clinical vetting process to match...
Digital substance use management platform Pelago, formerly Quit Genius, announced it secured $58 million in Series C funding, bringing its total raise to $151 million.
Existing investor Atomico led the round, with participation from other continuing investors, including Octopus Ventures, Y Combinator and Kinnevik AB. New investors GreyMatter Capital and Eight Roads also participated.
Laura...
In the midst of the COVID-19 pandemic, U.S. drug overdose deaths have surged. The CDC estimates that more than 107,000 people died in 2021, an increase of nearly 15% from the more than 93,000 deaths in 2020.
But the pandemic also has brought a sudden boost in telehealth utilization. Regulations surrounding telehealth prescriptions of controlled substances were loosened during the public health...
Virtual alcohol use disorder treatment company Ria Health completed an $18 million Series A funding round led by SV Health Investors.
Other participants in the round include SV limited partners, BPEA Private Equity and previous investor SOSV.
WHAT IT DOES
Ria provides virtual care for alcohol use disorder, including medication-assisted treatment like naltrexone, acamprosate and gabapentin that...
Virtual addiction treatment startup Boulder Care announced Friday it had received $36 million in Series B funding.
The round included participation by Qiming Venture Partners, Goodwater Capital and Laerdal Million Lives Fund as well as returning investors First Round Capital, Greycroft, Tusk Venture Partners and Gaingels.
Boulder said the Series B brings its total raise to more than $50 million....
Virtual addiction treatment Workit Health raised $118 million in Series C funding led by Insight Partners.
Other investors participating in the round include CVS Health Ventures, FirstMark Capital, BCBS Venture Fund, and 3L Capital.
"Workit is at the forefront of massive acceleration in telemedicine adoption, which is key to solving the overdose crisis that was exacerbated by COVID-19. The risk...
Quit Genius, a digital treatment platform for addiction, closed a $64 million Series B funding round. The round was co-led by Kinnevik and Atomico, with additional participation from Octopus Ventures, Triple Point Ventures and Startup Health.
This, in addition to the company's Series A round from last year, brings its total amount raised to $77.5 million.
WHAT THEY DO
Quit Genius offers treatment...
